Companies / BKD Brookdale Senior Living Inc. (BKD)
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.
Ticker BKD Exchange NYSE Sector Healthcare Industry Medical Care Facilities Market cap $2.15B 52-week range $8.02 - $17.09 Valuation Share price $9.01 (close of Nov 6, 2026) P/E (TTM) -53.00x Price to book -56.81x Price to free cash flow 148.05x Enterprise value $7.33B Book value per share $-0.16 Price performance Period Change 1 day -16.65% 5 days -13.28% 1 month -17.34% 3 months -37.26% 6 months -36.46% Year to date -16.50% 1 year -1.10% 3 years +118.69% 5 years +19.02% 10 years -27.92% All time -64.57%
Short interest As of Oct 15, 2026 Short % of float 19.38% Shares short 45.64M Days to cover 6.72 Change since prior report +1.08% Source FINRA consolidated short interest Profitability and growth Return on invested capital 0.25% Return on assets -4.41% Return on capital employed 0.25% Gross margin 26.22% Net margin -8.22% EBITDA margin 12.02% Revenue growth 2.19% Cash flow and balance sheet Free cash flow yield (TTM) 0.68% Current ratio 1.05x Net debt to EBITDA 10.26x Latest reported year Period end Dec 31, 2025 Fiscal year 2025 Revenue $3.19B Cost of revenue $2.99B Gross profit $837.55M EBITDA $383.80M Net income -$262.69M Earnings per share $-1.12 Shares outstanding 235.18M Income statement by year Period end Revenue Gross profit Net income EPS 2025-12-31 $3.19B $837.55M -$262.69M -$1.12 2024-12-31 $3.13B $799.31M -$201.94M -$0.89 2023-12-31 $3.02B $746.70M -$189.01M -$0.84 2022-12-31 $2.83B $594.41M -$238.43M -$1.25 2021-12-31 $2.76B $500.95M -$99.29M -$0.54 2020-12-31 $3.54B $797.15M $82.02M $0.45 2019-12-31 $4.06B $876.54M -$267.93M -$1.44 2018-12-31 $4.53B $1.07B -$528.26M -$2.82 2017-12-31 $4.75B $1.25B -$571.42M -$3.07 2016-12-31 $4.98B $1.44B -$404.40M -$2.18
Margins and returns by year Period end Gross margin Net margin Return on equity Return on capital 2025-12-31 26.22% -8.22% - 0.25% 2024-12-31 25.57% -6.46% -94.40% 0.71% 2023-12-31 24.76% -6.27% -46.65% 0.19% 2022-12-31 21.04% -8.44% -40.82% -0.75% 2021-12-31 18.16% -3.60% -14.19% -3.52% 2020-12-31 22.52% 2.32% 10.22% -1.56% 2019-12-31 21.61% -6.60% -38.35% -0.64% 2018-12-31 23.57% -11.66% -51.87% -9.85% 2017-12-31 26.41% -12.04% -37.34% -4.69% 2016-12-31 28.93% -8.13% -19.46% -0.55%
Cash and debt by year Period end Cash Debt 2025-12-31 $279.12M $4.22B 2024-12-31 $308.93M $4.02B 2023-12-31 $277.97M $3.66B 2022-12-31 $398.85M $3.78B 2021-12-31 $347.03M $3.78B 2020-12-31 $380.42M $3.85B 2019-12-31 $240.23M $3.22B 2018-12-31 $398.27M $3.35B 2017-12-31 $222.65M $3.38B 2016-12-31 $216.40M $3.41B
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-12-31 $16.50M $11.94M 2024-12-31 -$35.07M $14.18M 2023-12-31 -$70.28M $11.98M 2022-12-31 -$193.64M $14.47M 2021-12-31 -$271.29M $16.27M 2020-12-31 $19.78M $20.75M 2019-12-31 -$87.68M $23.03M 2018-12-31 -$21.51M $26.07M 2017-12-31 $164.47M $27.83M 2016-12-31 $40.00M $32.28M
Dividend history Most recent payment Oct 8, 2008 Payment date Dividend per share 2008-10-08 $0.25 2008-07-02 $0.25 2008-03-27 $0.25 2007-12-27 $0.50 2007-09-26 $0.50 2007-06-27 $0.50 2007-03-28 $0.45 2006-12-27 $0.45
Investor relations Past earnings dates Reported Fiscal period EPS estimate 2026-11-06 Sep 2026 -$0.02 2026-08-10 Jun 2026 -$0.04 2026-05-06 Mar 2026 $0.03 2026-02-18 Dec 2025 -$0.16 2025-11-06 Sep 2025 -$0.16 2025-08-06 Jun 2025 -$0.14 2025-05-06 Mar 2025 -$0.11 2025-02-18 Dec 2024 -$0.19
Filings and sources Company website brookdale.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports Similar companies HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades